These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9221279)

  • 1. Evidence that high dose cortisol-induced Na+ retention in man is not mediated by the mineralocorticoid receptor.
    Whitworth JA; Kelly JJ
    J Endocrinol Invest; 1995; 18(7):586-91. PubMed ID: 9221279
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence that high dose cortisol-induced Na+ retention in man is not mediated by the mineralocorticoid receptor.
    Montrella-Waybill M; Clore JN; Schoolwerth AC; Watlington CO
    J Clin Endocrinol Metab; 1991 May; 72(5):1060-6. PubMed ID: 1850752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of mineralocorticoid activity on transtubular potassium gradient, urinary [K]/[Na] ratio, and fractional excretion of potassium.
    Chacko M; Fordtran JS; Emmett M
    Am J Kidney Dis; 1998 Jul; 32(1):47-51. PubMed ID: 9669423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of fludrocortisone and spironolactone on sodium and potassium losses in secretory diarrhea.
    Wenzl HH; Fine KD; Santa Ana CA; Porter JL; Fordtran JS
    Dig Dis Sci; 1997 Jan; 42(1):119-28. PubMed ID: 9009126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacological action of 9alpha-fluorohydrocortisone as a mineralocorticoid].
    Sekihara H
    Nihon Rinsho; 1994 Mar; 52(3):583-6. PubMed ID: 8164353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response relationships and mineralocorticoid activity in cortisol-induced hypertension in humans.
    Williamson PM; Kelly JJ; Whitworth JA
    J Hypertens Suppl; 1996 Dec; 14(5):S37-41. PubMed ID: 9120683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The selective mineralocorticoid receptor modulator AZD9977 reveals differences in mineralocorticoid effects of aldosterone and fludrocortisone.
    Bamberg K; William-Olsson L; Johansson U; Jansson-Löfmark R; Hartleib-Geschwindner J
    J Renin Angiotensin Aldosterone Syst; 2019; 20(1):1470320319827449. PubMed ID: 30813831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of glucocorticoid and mineralocorticoid receptor stimulation on task switching.
    Deuter CE; Wingenfeld K; Schultebraucks K; Otte C; Kuehl LK
    Horm Behav; 2019 Mar; 109():18-24. PubMed ID: 30684522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenocorticotropin and cortisol-induced changes in urinary sodium and potassium excretion in man: effects of spironolactone and RU486.
    Clore JN; Estep H; Ross-Clunis H; Watlington CO
    J Clin Endocrinol Metab; 1988 Oct; 67(4):824-31. PubMed ID: 2843562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of mineralocorticoid agonists and antagonists on binding of 3 H-aldosterone to adrenalectomized rat kidney plasma membranes.
    Forte LR
    Life Sci I; 1972 May; 11(10):461-73. PubMed ID: 4348285
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of corticosteroids on urinary ammonium excretion in humans.
    Waybill MM; Clore JN; Emerick RA; Watlington CO; Schoolwerth AC
    J Am Soc Nephrol; 1994 Feb; 4(8):1531-7. PubMed ID: 8025226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldosterone-specific membrane receptors and rapid non-genomic actions of mineralocorticoids.
    Wehling M; Eisen C; Christ M
    Mol Cell Endocrinol; 1992 Dec; 90(1):C5-9. PubMed ID: 1338726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential contribution of mineralocorticoid and glucocorticoid receptors to memory formation during sleep.
    Groch S; Wilhelm I; Lange T; Born J
    Psychoneuroendocrinology; 2013 Dec; 38(12):2962-72. PubMed ID: 24035099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of mineralocorticoid receptors enhances naïve T-helper cell counts during early sleep in humans.
    Besedovsky L; Born J; Lange T
    Brain Behav Immun; 2012 Oct; 26(7):1116-21. PubMed ID: 22884414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paradoxical mineralocorticoid receptor-mediated effect in fear memory encoding and expression of rats submitted to an olfactory fear conditioning task.
    Souza RR; Dal Bó S; de Kloet ER; Oitzl MS; Carobrez AP
    Neuropharmacology; 2014 Apr; 79():201-11. PubMed ID: 24296155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoids with or without fludrocortisone in septic shock: a narrative review from a biochemical and molecular perspective.
    Nethathe GD; Lipman J; Anderson R; Fuller PJ; Feldman C
    Br J Anaesth; 2024 Jan; 132(1):53-65. PubMed ID: 38030548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spironolactone decreases the somatic signs of opiate withdrawal by blocking the mineralocorticoid receptors (MR).
    Navarro-Zaragoza J; Laorden ML; Milanés MV
    Toxicology; 2014 Dec; 326():36-43. PubMed ID: 25308750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of the mineralocorticoid receptor in healthy men: effects on experimentally induced panic symptoms, stress hormones, and cognition.
    Otte C; Moritz S; Yassouridis A; Koop M; Madrischewski AM; Wiedemann K; Kellner M
    Neuropsychopharmacology; 2007 Jan; 32(1):232-8. PubMed ID: 17035932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the mineralocorticoid activity of 18-hydroxy-11-deoxycorticosterone (18-OH-DOC) in the isolated toad bladder.
    Porter GA; Kimsey J
    Endocrinology; 1971 Aug; 89(2):353-7. PubMed ID: 5557989
    [No Abstract]   [Full Text] [Related]  

  • 20. Mineralocorticoid receptors/epithelial Na(+) channels in the choroid plexus are involved in hypertensive mechanisms in stroke-prone spontaneously hypertensive rats.
    Nakano M; Hirooka Y; Matsukawa R; Ito K; Sunagawa K
    Hypertens Res; 2013 Mar; 36(3):277-84. PubMed ID: 23096235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.